Szisztémás szklerózis (szkleroderma): vizsgálatok itt: Svédország
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study of AZD0120 in Autoimmune Diseases
- Where
- Huddinge
- Életkor
- 18 év to 75 év
- People
- 27 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07295847 - 3. fázisTaking peopleA Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Where
- Solna
- Életkor
- 18 év and over
- People
- 448 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07497087 · EU 2025-523884-39-00 - 1. fázisTaking peopleA Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Where
- Uppsala
- Életkor
- 12 év to 70 év
- People
- 244 worldwide
- Run by
- Fate Therapeutics
See details and how to joinNCT06308978 - 1. fázisNot yet taking people in SvédországExploratory, non-randomized, 3-group, microdosing clinical trial to investigate Gallium-68 (68Ga) labeled Platelet-Derived Growth Factor Beta (PDGFRß) targeting Positron Emission Tomography (PET) tracer (68Ga-ATH001) binding in the lungs in healthy participants versus participants with Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)
- Where
- Uppsala
- Életkor
- 18 év and over
- People
- 15
- Run by
- Antaros Medical AB
See details and how to join2026-525309-11-00 - No phaseTaking peopleEFESO: Study on Juvenile Onset Eosinophilic Fasciitis
- Where
- Solna
- Életkor
- Up to 18 év
- People
- 20 worldwide
- Run by
- Meyer Children's Hospital IRCCS
See details and how to joinNCT07348263 - No phaseTaking peopleWestern Sweden Systemic Sclerosis Project
- Where
- Gothenburg
- Életkor
- 18 év and over
- People
- 150
- Run by
- Sahlgrenska University Hospital
See details and how to joinNCT07345052 - 4. fázisCsak meghívásosVaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
- Where
- Lund
- Életkor
- 18 év and over
- People
- 240
- Run by
- Region Skane
See details and how to joinNCT06763783 - 4. fázisTaking peopleVaccination in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on the immunogenicity of herpes-zoster vaccine (Shingrix) and protection against infection (HZ-REUMA)
- Where
- Lund
- Életkor
- 18 év and over
- People
- 1
- Run by
- Region Skane Skanes Universitetssjukhus
See details and how to join2023-506230-71-01